4th Quarter - Report
CSL BEHRING LLC for CSL BEHRING LLC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Firm
Client
Income
—
Expenses
$170,000
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 8, 2015 | $170,000 | Replaced |
| 4th Quarter - Amendment | Jan 8, 2015 | $170,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Preserving Access to Orphan Drugs Act (HR 2315/S.1128) 21st Century Cures advocacy with House Energy & Commerce Committee Preservation of the Orphan Drug Tax Credit
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN R. BULLARD | Sr. Manager, Federal Gov't Affairs |
| PATRICK COLLINS | Director, Healthcare Policy & External Affairs |
| DENNIS JACKMAN | Sr. VP, Healthcare Policy & External Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.